Rahsaan Thompson
General Counsel at Zevra Therapeutics, Inc. (ZVRA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $969K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 17SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 42,66637,569 held (−53%) | $11.13 | $475K | -10.7% |
| Jun 23SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 34,55780,235 held (−30%) | $12.68 | $438K | -21.6% |
| May 13SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 1,79448,125 held (−4%) | $11.30 | $20K | -12.0% |
| Feb 2SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 4,08049,919 held (−8%) | $8.83 | $36K | +12.6% |
- Sell
General Counsel Rahsaan Thompson sold $475K of ZVRA at $11.13 — cuts the stake by 53%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Rahsaan Thompson sold $438K of ZVRA at $12.68 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Rahsaan Thompson sold $20K of ZVRA at $11.30 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Rahsaan Thompson sold $36K of ZVRA at $8.83 — pre-scheduled 10b5-1 plan sale.